| 1. |
The WHO supports global registration of trials |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 2. |
New EC regulations that will strengthen safeguards for patients in clinical trials came into effect on 1 May 2004 |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 3. |
Amphotericin B lipid complex best value lipid therapy in mycoses |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 4. |
Desloratadine a QOL tonic for chronic idiopathic urticaria, SAR |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 5-6
&NA;,
Preview
|
|
摘要:
Chronic idiopathic urticaria is a troubling dermatological condition that is defined as the daily, or almost daily, recurrence of urticarial wheals for more than 6 weeks for which no particular infectious, drug-induced or physical cause can be identified. It is characterised by repeated mediator release leading to red, raised, well-demarcated, itchy wheals (or hives), triggered by intolerance to food additives, infections or autoantibodies. Not surprisingly, chronic idiopathic urticaria has a significant negative impact on patients' social and psychological well-being. Avoidance of triggers may prove difficult in chronic idiopathic urticaria, hence, pharmacological treatment is recommended. Antihistamines are the first-line choice of therapy, with newer agents preferred over older ones, due to their nonsedating properties, and superior efficacy. Likewise, seasonal allergic rhinitis (SAR) causes bothersome symptoms which can affect patients' performance at work and school, and lead to poor QOL. Desloratadine is a potent, nonsedating H1-receptor antagonist that has been shown to effectively improve symptoms of chronic idiopathic urticaria and SAR. Two studies presented at a poster session at the 60th Annual Meeting of the American Academy of Allergy, Asthma and Immunology [San Francisco, US; March 2004] aimed to assess the symptom and QOL benefits of desloratadine in the treatment of patients with chronic idiopathic urticaria or SAR.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 5. |
Women with HIV infections who use HAART have levels of hospitalisation and emergency-department use equivalent to women without HIV infections, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 6. |
Stem cell transplantation successfully treats GVHD |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 7. |
n-3 PUFAs may stabilise myocardial excitability |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 8. |
Levosimendan has been used successfully in the treatment of a woman with peripartum cardiomyopathy |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 9-9
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 9. |
Eletriptan may be effective for the short-term prophylaxis of cluster headache, |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 10-10
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
| 10. |
Amlodipine and atorvastatin pair up in hypertension and hyperlipidaemia |
| |
Inpharma Weekly,
Volume &NA;,
Issue 1436,
2004,
Page 11-12
RM Poole,
Preview
|
|
摘要:
The combination of the calcium channel antagonist amlodipine plus atorvastatin administered as a single tablet [Caduet] is effective as either initial or integrated therapy for hypertension and hyperlipidaemia, according to a study presented at the 2004 Annual Scientific Sessions of the American College of Cardiology [New Orleans, US; March 2004]. This study, which involved more than 1200 patients with both hypertension and hyperlipidaemia, showed that treatment with amlodipine/atorvastatin enabled the majority of patients to achieve adequate control of BP and LDL-cholesterol levels.
ISSN:1173-8324
出版商:ADIS
年代:2004
数据来源: ADIS
|
首页
